|
1
|
Karachaliou N, Moreno MDLLG, Sosa AE, Santarpia M, Lazzari C, Capote AR, Massuti B, Rosell R. Using genetics to predict patient response to platinum-based chemotherapy. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT 2017. [DOI: 10.1080/23808993.2017.1298969] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Niki Karachaliou
- Instituto of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, Spain
| | | | - Aaron E. Sosa
- Instituto of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, Spain
| | - Mariacarmela Santarpia
- Medical Oncology Unit, Department of Human Pathology ‘‘G. Barresi’’, University of Messina, Messina, Italy
| | - Chiara Lazzari
- Department of Oncology, Division of Experimental Medicine, IRCCS San Raffaele, Milan, Italy
| | | | - Bartomeu Massuti
- Medical Oncology Service, Hospital General de Alicante, Alicante, Spain
| | - Rafael Rosell
- Instituto of Oncology Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain
- Laboratory of Cancer Molecular Biology, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain
- Cancer Biology & Precision Medicine Laboratory, Catalan Institute of Oncology (ICO), Germans Trias i Pujol University Hospital, Badalona, Spain
| |
Collapse
|
|
2
|
Cai X, Peng D, Wei H, Yang X, Huang Q, Lin Z, Xu W, Qian M, Yang C, Liu T, Yan W, Zhao J. miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncol Lett 2017; 13:2349-2353. [PMID: 28454402 PMCID: PMC5403480 DOI: 10.3892/ol.2017.5692] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2016] [Accepted: 01/18/2017] [Indexed: 02/02/2023] Open
Abstract
The expression of microRNA-215 (miR-215) in non-small cell lung cancer (NSCLC) tissues and the effects of miR-215 on the proliferation and migration of NSCLC cells were investigated. qRT-PCR was used to detect the expression of miR-215 in NSCLC tissues and paired normal tumor-adjacent lung tissues; MTT assay, transwell assay and soft-agar assay were used in vitro to evaluate the role of miR-215 on proliferation, migration and cell clonality on NSCLC cells, after transfecting miR-215 mimics to NSCLC cell line A549 or miR-215 to H1299. miR-215 was significantly decreased in NSCLC tissues compared to the paired normal tissues; Overexpression of miR-215 in A549 cells resulted in reduction of the cell proliferation, migration and cell clonality, while downregulation of miR-215 in H1299 cells could promote cell proliferation, migration and clonality. In conclusion, miR-215 was downregulated in NSCLC tissues and may play a key role in the development of NSCLC.
Collapse
Affiliation(s)
- Xiaopan Cai
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Dongyu Peng
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Haifeng Wei
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Xinghai Yang
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Quan Huang
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Zaijun Lin
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Wei Xu
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Ming Qian
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Cheng Yang
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Tielong Liu
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Wangjun Yan
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| | - Jian Zhao
- Department of Bone Tumor Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
| |
Collapse
|
|
3
|
Santarpia M, Rolfo C, Peters GJ, Leon LG, Giovannetti E. On the pharmacogenetics of non-small cell lung cancer treatment. Expert Opin Drug Metab Toxicol 2016; 12:307-17. [PMID: 26761638 DOI: 10.1517/17425255.2016.1141894] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Mariacarmela Santarpia
- Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy
| | - Christian Rolfo
- Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium
| | - G. J. Peters
- Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
| | - Leticia G. Leon
- Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
| | - Elisa Giovannetti
- Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
- Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
| |
Collapse
|